Recombinant Interleukins

 Recombinant Interleukins

Recombinant interleukins are bioengineered cytokines derived from the family of interleukins (ILs), which are key signaling molecules in the immune system. Interleukins mediate communication between immune cells, regulate inflammatory responses, and modulate cellular proliferation, differentiation, and apoptosis. Recombinant forms of interleukins are produced using advanced expression systems, such as bacteria (E. coli), yeast, mammalian cells (e.g., CHO, HEK293), or insect cells, to ensure their proper folding, activity, and biological functionality.

Content of Recombinant Interleukins

• Molecular Structure:
  • Interleukins are typically expressed as monomeric proteins, but some may naturally dimerize or oligomerize.
  • Recombinant versions include full-length proteins or truncated bioactive domains.
• Expression Systems:
  • E. coli: Ideal for cost-effective production; produces non-glycosylated forms.
  • Mammalian Cells: Ensures proper glycosylation and folding, critical for certain interleukins.
  • Yeast and Insect Cells: Offer intermediate glycosylation quality and scalability.
• Purity and Quality:
  • High purity levels (≥95% by SDS-PAGE or HPLC).
  • Endotoxin levels minimized for sensitive applications (<0.01 EU/µg).

Applications of Recombinant Interleukins

• Cellular and Molecular Studies:
  • Investigating receptor-ligand interactions, signaling pathways, and downstream effects.
  • Analyzing immune cell responses to specific interleukins in vitro and in vivo.
• Regenerative Medicine:
  • Using interleukins to modulate stem cell differentiation and tissue repair (e.g., IL-4 in wound healing).
  • Supporting chondrogenesis and cartilage repair (e.g., IL-1RA).
• Diagnostics:
  • As biomarkers for disease progression or treatment efficacy (e.g., IL-6 in inflammation and sepsis).
  • Development of diagnostic kits and assays involving recombinant interleukins.

Recombinant interleukins are indispensable tools for advancing our understanding of the immune system, developing targeted therapies, and improving diagnostic capabilities across a range of diseases.